Occam Places CFO for Prominent Swiss Biotech Alentis
.jpg)
In August 2024, Occam Global placed Jonathan Freve as Chief Financial Officer (CFO) of Alentis Therapeutics, a Jeito Capital, Novo Holdings, RA Capital, Bpifrance, and Schroders Capital investment.
Jon brings to Alentis over 20 years of financial experience in increasingly senior roles in the biotechnology sector. Most recently, he served as the CFO of Galecto, where he was responsible for leading financial operations, investor relations, and fundraising efforts. Before his role at Galecto, Jon was the CFO of Spring Bank Pharmaceuticals and held Corporate Controller positions at other publicly traded global companies.
Jon is a CPA who has worked on several successful initial public offerings, secondary offerings, mergers, and acquisitions. He holds a Bachelor’s degree in Business Administration from the University of Massachusetts Amherst.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.